University research records
Hong Kong Metropolitan University
6 imported, source-linked research records. Published in the last five years.
Published in the last five years
Back to university profile →6 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Hong Kong Metropolitan University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–6 of 6 matching records. Counts update as records arrive.
Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling
February 22, 2026 · 1 citations · Open access
Open original record →New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study
November 14, 2023 · 12 citations · Open access
Open original record →Lower risks of new-onset hip fracture risks in users of sodium glucose cotransporter 2 (SGLT2) inhibitors versus users of dipeptidyl peptidase-4 (DPP4) inhibitors: a propensity score-matched analysis
November 1, 2023 · 1 citations · Open access
Open original record →Sodium‐glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new‐onset overall cancer in Type 2 diabetes mellitus: A population‐based study
May 6, 2023 · 37 citations · Open access
Open original record →Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong
March 31, 2023 · 24 citations · Open access
Open original record →Lower risks of sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset hip fracture risks in patients with type-2 diabetes: A propensity score-matched study with competing risk analysis
February 19, 2023 · 0 citations · Open access
Open original record →